About
Drug Delivery
Areas of Focus
Categories
Drug Delivery & Formulation
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
12
As Collaborator
0
Total Enrollment
2,340
By Phase
PHASE4: 1PHASE3: 2PHASE2: 2PHASE2/PHASE3: 1NA: 1PHASE1: 1
By Status
COMPLETED: 12
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06329661Lead Sponsor
A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With Cyclosporine
PHASE4Completed
204 participants
Started: Apr 22, 2024 · Completed: Jul 30, 2025
NCT04523142Lead Sponsor
CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease in Subjects Who Completed CYS-004
PHASE3Completed
202 participants
Started: Jan 4, 2021 · Completed: May 23, 2022
NCT04523129Lead Sponsor
ESSENCE 2: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
PHASE3Completed
834 participants
Started: Dec 5, 2020 · Completed: Oct 8, 2021
NCT04521465Lead Sponsor
Safety and Efficacy of NovaTears® + Omega-3 (0.2%) Eye Drops on Signs and Symptoms of Dry Eye
N/ACompleted
36 participants
Started: Nov 9, 2020 · Completed: Feb 17, 2021
NCT03333057Lead Sponsor
Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
PHASE2Completed
336 participants
Started: Jan 3, 2018 · Completed: Jul 27, 2018
Locations (1)
Headquarters
Heidelberg, Germany
Map
Loading map...